Market Tracker

03/04 6:02pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

11.54
Delayed Data
As of Mar 04
 +0.69 / +6.36%
Today’s Change
3.44
Today|||52-Week Range
11.68
+22.90%
Year-to-Date

Today’s Trading

Previous close10.85
Today’s open10.83
Day’s range10.75 - 11.65
Volume1,499,849
Average volume (3 months)508,926
Market cap$416.5M
Dividend yield--
Data as of 4:00pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)+49.19%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book4.98

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...+0.71+2.99%
PRQRProQR Therapeutics N...+1.29+7.09%
TKMRTekmira Pharmaceutic...+1.52+8.32%
LBIOLion Biotechnologies...-0.07-0.74%
Data as of 4:00pm ET, 03/04/2015

Financials

Next reporting dateMay 18, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts